Ikarian Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $558K | Sell |
|
|||||
|
2023
Q1 | $7.32M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $102K | Sell |
|
|||||
|
2022
Q2 | $632K | Sell |
|
|||||
|
2022
Q1 | $2.85M | Buy |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $60K | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Hold |
|